| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |